Explore the best free AI tools for teachers in 2026. From lesson planning and grading to research and design, these tools ...

A high school teacher uses her state’s testing blueprint to give students practice with the standards and question types they’ll encounter most frequently.

Join Morgan as she unboxes and reviews the Cafflano Classic, an all-in-one portable coffee system featuring a hand grinder, ...

Exclusive: DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease Scientists have developed a simple DNA blood test that can predict how ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

AI study planners help students turn assignments, exams, and deadlines into smart, flexible schedules. These tools use AI to personalize plans, auto-adjust missed tasks, integrate calendars, and even ...

Roche Holding shares rose 2.1% Wednesday after the Swiss drugmaker reported positive results from a new study of an experimental breast cancer drug. The pill, giredestrant, reduced the risk of death ...

Nearly one in ten people over the age of 70 have Alzheimer’s disease dementia, shows a first-of-its-kind study that paired blood-based markers and clinical assessments to study the disease in Norway 1 ...

Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Abbott Laboratories is nearing a potential acquisition of cancer screening company Exact Sciences Corp., people familiar with the matter said, in what could be the biggest deal of the year in the ...

Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw share values slide after the first day of trading. The Menlo Park, ...